![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4745 | (2006.01) |
A61P 35/00 | (2006.01) | ||
A61P 13/00 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 47/10 | (2017.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/40 | (2006.01) |
(11) | Number of the document | 3091978 |
(13) | Kind of document | T |
(96) | European patent application number | 15702368.0 |
Date of filing the European patent application | 2015-01-08 | |
(97) | Date of publication of the European application | 2016-11-16 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2015/000022 |
Date | 2015-01-08 |
(87) | Number | WO 2015/104219 |
Date | 2015-07-16 |
(30) | Number | Date | Country code |
PCT/EP2014/000045 | 2014-01-10 | WO |
(72) |
HOLLDACK, Johanna , CH
HOLDEN, Stuart , US
POZZI, Raffaella , IT
|
(73) |
Urogen Pharma Ltd. ,
9 Ha`Tassiya Street, 4365007 Ra`anana,
IL
|
(54) | PHARMACEUTICAL COMPOSITIONS COMPRISING IMIQUIMOD FOR USE IN THE TREATMENT OF CARCINOMA IN SITU OF THE BLADDER |
PHARMACEUTICAL COMPOSITIONS COMPRISING IMIQUIMOD FOR USE IN THE TREATMENT OF CARCINOMA IN SITU OF THE BLADDER |